CHO PHARMA USA INC has a total of 15 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are NKARTA INC, ORIGINCELL THERAPEUTICS CO LTD and ARCELLX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Israel | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Chen Lan Bo | 13 |
#2 | Lan Bo Chen | 1 |
Publication | Filing date | Title |
---|---|---|
US2019298828A1 | Monoclonal antibodies that bind to SSEA4 and uses thereof | |
US2019290744A1 | Chimeric antigen receptors that bind to SSEA4 and uses thereof |